Piedmont Investment Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
EAM
CTA
EA
EMFAT
GIP
Piedmont Investment Advisors's NEO Position: Q2 2019 in Review
Piedmont Investment Advisors sold out of NeoGenomics (NEO) in Q2 2019, closing a stake of 23,321 shares — an estimated $477K sold.
Piedmont Investment Advisors first reported a position in NEO in Q2 2018 and held it in 2 quarters. The position peaked at $477K in Q1 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q2 2019.
- Piedmont Investment Advisors reported no remaining NeoGenomics position as of Q2 2019 after selling out during the quarter.
- Piedmont Investment Advisors sold 23,321 NeoGenomics shares in Q2 2019, an estimated $477K.
- Piedmont Investment Advisors first reported a position in NeoGenomics in Q2 2018 and held it in 2 quarters.
- Piedmont Investment Advisors's NeoGenomics position peaked at $477K in Q1 2019.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2019.
Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.